Notably, Aβ pathology was associated with decreased expression of the miR-155-5p target Socs1 (Figure 1A), likely contributing to an increase in inflammatory processes in the AD brain alongside increased expression of IL-6 (Guedes et al., 2014) and other pro-inflammatory molecules. Here, IL6 is linked to Alzheimer disease.